Get Live Data

Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Apax Global Alpha Share Price
  4. Apax Global Alpha Share Regulatory News
  5. Shire

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Apax Global Alpha Information

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.40
Bid: 150.00
Ask: 152.00
Change: -1.20 (-0.79%)
Spread: 2.00 (1.333%)
Open: 153.80
High: 154.00
Low: 150.40
Prev. Close: 151.60
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shire

19 Dec 2018 18:30

RNS Number : 0422L
FTSE Russell
19 December 2018
 

 

 

 

Further to the FTSE notice released on 18 December 2018 in relation to Takeda Pharmaceutical (Japan): Acquisition of Shire (UK), please note the replacement within the fixed index.

 

All other details remain unchanged. Please see updated notice below:

 

Takeda Pharmaceutical (Japan): Acquisition of Shire (UK)Changes in FTSE UK Index Series

19 December 2018

Further to the FTSE Russell notice published on 14 December 2018, in relation to the acquisition of Shire (UK, constituent) by Takeda Pharmaceutical (Japan, non-constituent), please see details of affected indexes and effective dates below:

 

Shire (UK, B2QKY05) will be deleted from the FTSE 100 index.

 

Hikma Pharmaceuticals (UK, B0LCW08) will be added to the FTSE 100 Index and removed from the FTSE 250 Index.

 

Apax Global Alpha (UK, BWWYMV8) will be added to the FTSE 250 index.

 

All changes effective from 24 December 2018.

 

Full Index changes details available on FTSE Russell website.

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2018 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSGMMMZRLRGRZM
12345678
Date   Source Headline
7th May 20247:00 amRNSApax IX agrees to sell Healthium
2nd May 20247:00 amRNSAudit Committee Change
2nd May 20247:00 amRNSResult of AGM
2nd May 20247:00 amRNSQuarterly Results to 31 March 2024
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts
12345678

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.